The growth-promoting action of individual women's sera on mammary carcinoma cells

Anticancer Research

Volumn 28, Issue 4 B, 2008, Pages 2213-2217

  Auer, Doris ^a   Hubalek, Michael ^a   Fleischer, Martina ^a   Roessler, Julia ^a   Daxenbichler, Guenter ^a,b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Universitaetsklinik f Frauenheilkunde   (Austria)

Author keywords

Breast cancer; In vitro assay; MCF 7; Steroids; Tamoxifen

Indexed keywords

ANASTROZOLE; ESTRADIOL; PRASTERONE SULFATE; PROGESTERONE; TAMOXIFEN; TIBOLONE;

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GROWTH; CANCER RISK; CARCINOMA CELL; CONTROLLED STUDY; CULTURE MEDIUM; HORMONE SENSITIVITY; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; SERUM;

AGE FACTORS; AROMATASE INHIBITORS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CULTURE MEDIA; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; NITRILES; NORPREGNENES; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SERUM; TAMOXIFEN; TRIAZOLES;

EID: 49049119076     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Simpson ER and Davis SR: Minireview: Aromatase and the regulation of estrogen biosynthesis - some new perspectives. Endocrinology 142: 4589-4594, 2001.
2. Beral V: Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362: 419-427, 2003.
3. Seeger H, Wallwiener D and Mueck AO: The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells. Horm Metab Res 35: 76-80, 2003.
4. Ursin G, Tseng CC, Paganini-Hill A, Enger S, Wan PC, Formenti S, Pike MC and Ross RK: Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? J Clin Oncol 20: 699-706, 2002.
5. Missmer SA, Eliassen AH, Barbieri RL and Hankinson SE: Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96: 1856-1865, 2004.
6. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M and Hankinson SE: Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 98: 1406-1415, 2006.
7. Adly L, Hill D, Sherman ME, Sturgeon SR, Fears T, Mies C, Ziegler RG, Hoover RN and Schairer C: Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women. Int J Cancer 119: 2402-2407, 2006.
8. Pasqualini JR, Sumida C and Giambiagi N: Pharmacodynamic and biological effects of anti-estrogens in different models. J Steroid Biochem 31: 613-643, 1988.
9. Miller WR, Anderson TJ, Evans DB, Krause A, Hampton G and Dixon JM: An integrated view of aromatase and its inhibition. J Steroid Biochem Mol Biol 86: 413-421, 2003.